Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Psychiatry Research

• Publication date

  1997-11-28

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0925-4927(97)00057-7PMID 9498309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET

  2005cited by this paper
• Predictors of response to clozapine therapy

  2004cited by this paper
• PET and MRI of the thalamus in never-medicated patients with schizophrenia.

  1996cited by this paper
• [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.

  1996cited by this paper
• The thalamus as a site of action of antipsychotic drugs.

  1996cited by this paper
• SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

  1996cited by this paper
• Effects of Olanzapine on Regional C-Fos Expression in Rat Forebrain

  1996cited by this paper
• Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms.

  1996cited by this paper
• Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.

  1996cited by this paper
• SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

  1996cited by this paper
• Association between clozapine response and allelic variation in 5-HT2A receptor gene.

  1995cited by this paper
• Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia.

  1995cited by this paper
• Clozapine increases EEG photic driving in clinical responders.

  1995cited by this paper
• High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients.

  1995cited by this paper
• Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.

  1995cited by this paper
• Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.

  1995cited by this paper
• No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

  1995cited by this paper
• Frontal-subcortical circuits and neuropsychiatric disorders.

  1994cited by this paper
• Clozapine effects on glucose metabolic rate in striatum and frontal cortex.

  1994cited by this paper
• Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.

  1994cited by this paper
• Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.

  1994cited by this paper
• Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

  1994cited by this paper
• Relationship between brain structure and function in disorders of the schizophrenic spectrum: single positron emission computerized tomography, computerized tomography and psychopathology of first episodes

  1994cited by this paper
• Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.

  1993cited by this paper
• Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users.

  1993cited by this paper
• Modulation of Central Cholinergic Activity by GABA and Serotonin: PET Studies with 11C-Benztropine in Primates

  1993cited by this paper
• Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.

  1993cited by this paper
• Accuracy of registration of PET, SPECT and MR images of a brain phantom.

  1993cited by this paper
• Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers

  1993cited by this paper
• Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.

  1992cited by this paper
• Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

  1992cited by this paper
• Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

  1992cited by this paper
• Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.

  1992cited by this paper
• Dopamine receptor genes: new tools for molecular psychiatry.

  1992cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Codistribution of a sensory gating deficit and schizophrenia in multi-affected families.

  1991cited by this paper
• Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia.

  1991cited by this paper
• Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.

  1991cited by this paper
• Changes in brain glucose metabolism in cocaine dependence and withdrawal.

  1991cited by this paper
• Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET.

  1990cited by this paper
• Neurotransmitters and neuromodulators in the basal ganglia.

  1990cited by this paper
• Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.

  1990cited by this paper
• Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

  1990cited by this paper
• Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.

  1990cited by this paper
• The use of c-fos as a metabolic marker in neuronal pathway tracing.

  1989cited by this paper
• Positron emission tomography and subcortical glucose metabolism in schizophrenia.

  1988cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.

  1988cited by this paper
• Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

  1987cited by this paper
• Dopamine D2 receptors in schizophrenia studied in vivo.

  1986cited by this paper
• Human striatal dopamine receptors are organized in compartments.

  1986cited by this paper
• Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

  1986cited by this paper
• Regional and Cortical Laminar Distributions of Serotonin S2, Benzodiazepine, Muscarinic, and Dopamine D2 Receptors in Human Brain

  1984cited by this paper

• Neuropsychiatric update: neuroimaging schizophrenia.

  2025cites this paper
• Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow

  2024influential citation
• Neurostructural changes in schizophrenia and treatment-resistance: a narrative review

  2024cites this paper
• A systematic review of neuroimaging studies of clozapine-resistant schizophrenia

  2023influential citation
• Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis

  2023cites this paper
• Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration

  2022cites this paper
• Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study.

  2022cites this paper
• Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.

  2022cites this paper
• Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies.

  2022cites this paper
• Effect of cannabidiol on schizophrenia based on randomized controlled trials: A meta-analysis

  2021cites this paper
• Quantitative biomarkers to predict response to clozapine treatment using resting EEG data.

  2020cites this paper
• A Machine Learning Approach Using Effective Connectivity to Predict Response to Clozapine Treatment

  2020cites this paper
• Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie

  2020cites this paper
• Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate

  2019cites this paper
• Neuroimaging: Diagnostic Boundaries and Biomarkers

  2019cites this paper
• Biological Predictors of Clozapine Response: A Systematic Review

  2018cites this paper
• S0033291718000041jra 2418..2427

  2018cites this paper
• Treatment-Resistant Schizophrenia: Assessment and Management

  2018cites this paper
• Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia

  2018cites this paper
• Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.

  2016cites this paper
• The neurobiological basis of treatment response in psychosis

  2016cites this paper
• Treatment resistant schizophrenia: Course of brain structure and function.

  2016cites this paper
• Personalised approaches to pharmacotherapy for schizophrenia

  2016cites this paper
• Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.

  2015influential citation
• Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review.

  2015cites this paper
• A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: Association with response to treatment

  2014cites this paper
• Synaptic Proteins in the Postmortem Anterior Cingulate Cortex in Schizophrenia: Relationship to Treatment and Treatment Response

  2014cites this paper
• The function of efference copy signals: implications for symptoms of schizophrenia.

  2013cites this paper
• A Proposal for Reframing Schizophrenia Research

  2013cites this paper
• Ultrastructural Distinctions Between Treatment Responders and Non-Responders in Schizophrenia: Postmortem Studies of the Striatum

  2012cites this paper
• Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings.

  2012influential citation
• Prefrontal networks in schizophrenia: insights from neuroimaging

  2012cites this paper
• Imaging genomics and response to treatment with antipsychotics in schizophrenia

  2011cites this paper
• Mitochondria in the striatum of subjects with schizophrenia: Relationship to treatment response

  2011influential citation
• Factors associated with response to clozapine in schizophrenia: a review.

  2011cites this paper
• Tempo de resposta a tratamento antipsicótico na esquizofrenia de início recente: um estudo randomizado e controlado de 12 semanas

  2010cites this paper
• Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry.

  2010cites this paper
• Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia.

  2010cites this paper
• Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia

  2009cites this paper
• The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response.

  2009influential citation
• Treatment-resistant schizophrenia.

  2007cites this paper
• The effect of clozapine on neuroimaging findings in schizophrenia.

  2007cites this paper
• Marked Hypofrontality in Clozapine-responsive Patients

  2007cites this paper
• Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study.

  2007cites this paper
• Treatment-Resistant Schizophrenia.

  2007cites this paper
• Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

  2005cites this paper
• Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia

  2005cites this paper
• Predictors and markers of clozapine response

  2005cites this paper
• Pathologie des Thalamus und Schizophrenie - Ein Überblick

  2004cites this paper
• [Pathology of the thalamus and schizophrenia--an overview].

  2004cites this paper
• Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.

  2004cites this paper
• Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.

  2003cites this paper
• Caudate and putamen volumes in good and poor outcome patients with schizophrenia.

  2003cites this paper
• The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.

  2003cites this paper
• Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.

  2003cites this paper
• Subcortical overactivation in untreated schizophrenic patients: A functional magnetic resonance image finger‐tapping study

  2002cites this paper
• SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.

  2002cites this paper
• EEG Alpha Rhythm and Glucose Metabolic Rate in the Thalamus in Schizophrenia

  2001cites this paper
• Thalamic volumes in patients with first-episode schizophrenia.

  2001cites this paper
• Practice-related improvement in information processing with novel antipsychotic treatment.

  2000cites this paper
• Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK‐801) injures pyramidal neurons in rat retrosplenial cortex

  2000cites this paper
• Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study.

  1999cites this paper